Innate Pharma (OTCMKTS:IPHYF – Get Free Report) and Bio-Techne (NASDAQ:TECH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations. Risk & Volatility Innate Pharma has a beta of […]
Innate Pharma S.A. (OTCMKTS:IPHYF – Get Free Report) saw a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 100 shares, a decline of 75.0% from the July 31st total of 400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio […]
Innate Pharma S.A. (OTCMKTS:IPHYF – Get Rating) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 100 shares, a decline of 75.0% from the April 30th total of 400 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is […]
Innate Pharma S.A. (OTCMKTS:IPHYF – Get Rating) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 200 shares, a drop of 97.8% from the March 31st total of 9,200 shares. Based on an average daily volume of 0 shares, the […]
Innate Pharma S.A. (OTCMKTS:IPHYF – Get Rating) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 9,200 shares, a decline of 27.6% from the March 15th total of 12,700 shares. Based on an average trading volume of 100 shares, the short-interest ratio is […]